INM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - InMed Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 1.375 USD 1.1% Market Closed

Market Cap: $7.4m

	InMed Pharmaceuticals Inc NASDAQ:INM	CA
	Aviva PLC F:GU81	UK
Y	Yaskawa Electric Corp F:YEC	JP
	Millicom International Cellular SA NASDAQ:TIGO	LU
G	Grand Canyon Education Inc SWB:GKD	US
	Real Matters Inc TSX:REAL	CA
	Norsk Hydro ASA OSE:NHY	NO
L	Lincoln Electric Holdings Inc SWB:LNE	US
P	Performance Food Group Co F:P5F	US
E	East Asia Holdings Investment Ltd KOSDAQ:900110	HK
C	Capital A Berhad KLSE:CAPITALA	MY
	Coca-Cola HBC AG LSE:CCH	CH
	Laureate Education Inc NASDAQ:LAUR	US

Profitability Summary

InMed Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

29%

Negative Operating Margin

-263%

Negative 3Y Average Operating Margin

-181%

Declining Operating Margin

-160% > -263%

Negative Net Margin

-262%

Negative 3Y Average Net Margin

-178%

Declining Net Margin

-148% > -262%

Negative Free Cash Flow Margin

-230%

Negative 3Y Average Free Cash Flow Margin

-168%

Declining Free Cash Flow Margin

-153% > -230%

Negative ROE

-122%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-176%

Declining ROIC

-192% > -222%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.